The estimate starts with imaging and technical feasibility
Current CT or MRI is needed to decide whether a lesion can be safely reached and whether a sufficient ablation margin appears feasible. If the tumor is too large, too close to a vulnerable structure or better treated by surgery, TACE, SIRT, radiation or systemic therapy, the proposed procedure and price can change before travel.
Major cost drivers
Ask the hospital to define the assumed scope of the ablation episode.
- Interventional-radiology and multidisciplinary case review
- Pre-procedure CT, MRI, ultrasound or laboratory testing when required
- RFA electrode or microwave antenna system
- Number of tumors and number of applicator placements
- CT, ultrasound or combined image guidance
- Local anesthesia, sedation or general anesthesia
- Inpatient or monitored overnight stay
- Contrast-enhanced post-treatment imaging
- Pathology or biopsy if separately required
- Treatment of bleeding, infection or other complications
Multiple lesions can make one headline price misleading
A single small peripheral lesion is not financially comparable with several lesions requiring multiple needle positions, repeated ablation cycles or treatment in more than one session. The written estimate should specify how many tumors and applicators it assumes.
Ask whether biopsy is included or separate
Some cases already have a secure diagnosis from imaging and prior pathology, while others require tissue sampling. If biopsy is planned during the same admission or as a separate procedure, clarify whether pathology and molecular testing are included in the estimate.
Follow-up imaging and repeat ablation can create additional costs
Ablation success is assessed on contrast-enhanced imaging. If viable tumor remains or a new lesion appears, repeat ablation or a different liver-directed treatment may be considered. International patients should ask which follow-up is included and which later treatment would require a new quotation.
Official sources
Sources last checked 2026-09-07.